NEUROPATHIX, INC. (NPTX) financial statements (2022 and earlier)

Company profile

Business Address 3805 OLD EASTON ROAD
DOYLESTOWN, PA 18902
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

9/30/2021
TTM
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 221212,88720
Cash and cash equivalents 2212130720
Short-term investments   2,580  
Receivables     10
Prepaid expense 1619   
Other undisclosed current assets 001160 
Total current assets: 1831313,003210
Noncurrent Assets
Property, plant and equipment 59753  
Deposits noncurrent assets   17  
Other undisclosed noncurrent assets 1717   
Total noncurrent assets: 769320  
TOTAL ASSETS: 2602233,023210
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including: 721389284117
Accounts payable 128  117
Accrued liabilities 379243246  
Employee-related liabilities 230243   
Interest and dividends payable 0    
Other undisclosed accounts payable and accrued liabilities (16)(97)38  
Debt 1,1906621645 
Derivative instruments and hedges, liabilities 138183   
Due to related parties 5525  20
Other liabilities    5 
Other undisclosed current liabilities 44167246  
Total current liabilities: 2,5461,3275465136
Noncurrent Liabilities
Long-term debt and lease obligation 44637926  
Long-term debt, excluding current maturities 44637926  
Liabilities, other than long-term debt 178183   
Derivative instruments and hedges, liabilities 178183   
Other undisclosed noncurrent liabilities 284281,120  
Total noncurrent liabilities: 9095901,146  
Total liabilities: 3,4541,9171,6925136
Stockholders' equity
Stockholders' equity attributable to parent, including: (3,195)(1,694)1,331(49)(26)
Common stock 87711
Additional paid in capital 9,8316,7956,3823535
Accumulated deficit (13,033)(8,496)(5,052)(85)(62)
Other undisclosed stockholders' equity attributable to parent   (6)  
Total stockholders' equity: (3,195)(1,694)1,331(49)(26)
TOTAL LIABILITIES AND EQUITY: 2602233,023210

Income statement (P&L) ($ in thousands)

9/30/2021
TTM
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
Revenues 108126174135
Realized investment gains   3,902  
Other income 108    
Cost of revenue   (62) (21)
Provision for loan, lease, and other losses   (62)
Gross profit: 108126112114
Operating expenses (4,474)(2,455)(1,236)(24)(46)
Other undisclosed operating income (loss) (108) 62  
Operating loss: (4,474)(2,329)(1,062)(22)(32)
Nonoperating income (expense) (64)(1,122)2,805  
Interest and debt expense (924)(147)   
Income (loss) from continuing operations before equity method investments, income taxes: (5,462)(3,598)1,743(22)(32)
Other undisclosed income from continuing operations before income taxes 924147   
Income (loss) from continuing operations before income taxes: (4,537)(3,451)1,743(22)(32)
Income tax expense   (812)  
Net income (loss): (4,537)(3,451)931(22)(32)
Net income attributable to noncontrolling interest  76  
Other undisclosed net loss attributable to parent  (7)   
Net income (loss) attributable to parent: (4,537)(3,451)937(22)(32)
Other undisclosed net income available to common stockholders, basic  7   
Net income (loss) available to common stockholders, diluted: (4,537)(3,444)937(22)(32)

Comprehensive Income ($ in thousands)

9/30/2021
TTM
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
Net income (loss): (4,537)(3,451)931(22)(32)
Comprehensive income (loss): (4,537)(3,451)931(22)(32)
Comprehensive income, net of tax, attributable to noncontrolling interest  76  
Comprehensive income (loss), net of tax, attributable to parent: (4,537)(3,444)937(22)(32)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: